| S7223 |
RepSox |
RepSox is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation, respectively. |
Selective |
TGFβR1(ALK5), IC50: 4 nM |
| S1476 |
SB525334 |
SB525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6. |
Selective |
TGFβR1(ALK5), IC50: 14.3 nM |
| S2750 |
GW788388 |
GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, also inhibits TGF-β type II receptor and activin type II receptor activities, but does not inhibit BMP type II receptor. |
Selective |
ALK5, IC50: 18 nM |
| S7624 |
SD-208 |
SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, >100-fold selectivity over TGF-βRII.
|
Selective |
TGF-βRI (ALK5), IC50: 48 nM |
| S2230 |
Galunisertib (LY2157299) |
Galunisertib (LY2157299) is a potent TGFβ receptor I (TβRI) inhibitor with IC50 of 56 nM. Phase 2/3. |
Selective |
TβRI, IC50: 56 nM |
| S7530 |
EW-7197 |
EW-7197 is a highly potent, selective, and orally bioavailable TGF-β receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively. Phase 1.
|
Pan |
ALK5, IC50: 11 nM |
| S2704 |
LY2109761 |
LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2. |
Pan |
TβRI, Ki: 38 nM |
| S2186 |
SB505124 |
SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5 with IC50 of 129 nM and 47 nM, respectively, also inhibits ALK7, but does not inhibit ALK1, 2, 3, or 6. |
Pan |
ALK5, IC50: 47 nM |
| S2805 |
LY364947 |
LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM, shows 7-fold selectivity over TGFβR-II. |
Pan |
TGFβRI, IC50: 59 nM |
| S1067 |
SB431542 |
SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM, 100-fold more selective for ALK5 than p38 MAPK and other kinases. |
Pan |
ALK5, IC50: 94 nM |
| S7359 |
K02288 |
K02288 is a potent, and selective type I BMP receptor inhibitor with IC50 of 1.1, 1.8, 6.4 nM for ALK2, ALK1 and ALK6, showing weaker inhibition on other ALKs (3, 4, 5) and ActRIIA. |
Pan |
ALK5, IC50: 321 nM; ALK5, IC50: 321 nM |
| S7147 |
LDN-212854 |
LDN-212854 is a potent and selective BMP receptor inhibitor with IC50 of 1.3 nM for ALK2, about 2-, 66-, 1641-, and 7135-fold selectivity over ALK1, ALK3, ALK4, and ALK5, respectively. |
Pan |
ALK5, IC50: 9276 nM |